- Home
- Publications
- Publication Search
- Publication Details
Title
PARkinson's: From cellular mechanisms to potential therapeutics
Authors
Keywords
Parkinson's disease, PARP-1, Poly(ADP-ribose), PARP inhibitor, Parthanatos
Journal
PHARMACOLOGY & THERAPEUTICS
Volume -, Issue -, Pages 107968
Publisher
Elsevier BV
Online
2021-08-12
DOI
10.1016/j.pharmthera.2021.107968
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HPF1 remodels the active site of PARP1 to enable the serine ADP-ribosylation of histones
- (2021) Fa-Hui Sun et al. Nature Communications
- Evaluation of a Low-Toxicity PARP Inhibitor as a Neuroprotective Agent for Parkinson’s Disease
- (2021) Laura N. Puentes et al. MOLECULAR NEUROBIOLOGY
- Poly (ADP-ribose) Interacts With Phosphorylated α-Synuclein in Post Mortem PD Samples
- (2021) Laura N. Puentes et al. Frontiers in Aging Neuroscience
- Posttranslational Modifications Mediate the Structural Diversity of Tauopathy Strains
- (2020) Tamta Arakhamia et al. CELL
- HPF1 completes the PARP active site for DNA damage-induced ADP-ribosylation
- (2020) Marcin J. Suskiewicz et al. NATURE
- Gut-seeded α-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice
- (2020) Collin Challis et al. NATURE NEUROSCIENCE
- A Phase I/II Study of Veliparib (ABT-888) with Radiation and Temozolomide in Newly Diagnosed Diffuse Pontine Glioma: A Pediatric Brain Tumor Consortium Study
- (2020) P A Baxter et al. NEURO-ONCOLOGY
- Poly(ADP-ribose): A Dynamic Trigger for Biomolecular Condensate Formation
- (2020) Anthony K.L. Leung TRENDS IN CELL BIOLOGY
- Poly (ADP‐ribose) polymerase 1 inhibition prevents neurodegeneration and promotes α‐synuclein degradation via transcription factor EB‐dependent autophagy in mutant α‐synucleinA53T model of Parkinson's disease
- (2020) Kanmin Mao et al. AGING CELL
- Levodopa/carbidopa/entacapone for the treatment of early Parkinson’s disease: a meta-analysis
- (2020) Xiaoli Liao et al. NEUROLOGICAL SCIENCES
- Structural basis for allosteric PARP-1 retention on DNA breaks
- (2020) Levani Zandarashvili et al. SCIENCE
- The Multifactorial Role of PARP-1 in Tumor Microenvironment
- (2020) Juan Manuel Martí et al. Cancers
- Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins
- (2019) Elizaveta E Alemasova et al. NUCLEIC ACIDS RESEARCH
- Advances in the use of PARP inhibitors for BRCA1/2-associated breast cancer: talazoparib
- (2019) Kelly E McCann Future Oncology
- PARylation regulates stress granule dynamics, phase separation, and neurotoxicity of disease-related RNA-binding proteins
- (2019) Yongjia Duan et al. CELL RESEARCH
- New insights of poly(ADP-ribosylation) in neurodegenerative diseases: A focus on protein phase separation and pathologic aggregation
- (2019) Cong Liu et al. BIOCHEMICAL PHARMACOLOGY
- Current status and future prospects of PARP inhibitor clinical trials in ovarian cancer
- (2019) Xuan Jiang et al. Cancer Management and Research
- Novel insights into PARPs in gene expression: regulation of RNA metabolism
- (2019) Yueshuang Ke et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Olaparib in germline-mutated metastatic breast cancer: implications of the OlympiAD trial
- (2019) Anne C Armstrong et al. Future Oncology
- Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson’s Disease
- (2019) Sangjune Kim et al. NEURON
- PARP1 and Poly(ADP-ribosyl)ation Signaling during Autophagy in Response to Nutrient Deprivation
- (2019) José Manuel Rodríguez-Vargas et al. Oxidative Medicine and Cellular Longevity
- BRCA Mutation Carriers: Breast and Ovarian Cancer Screening Guidelines and Imaging Considerations
- (2019) Mai Elezaby et al. RADIOLOGY
- Alpha-synuclein is a DNA binding protein that modulates DNA repair with implications for Lewy body disorders
- (2019) Allison J. Schaser et al. Scientific Reports
- Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer
- (2019) Robert L. Coleman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial
- (2018) Sibylle Loibl et al. LANCET ONCOLOGY
- Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease
- (2018) Xian-Si Zeng et al. Frontiers in Aging Neuroscience
- Poly(ADP-Ribose) Prevents Pathological Phase Separation of TDP-43 by Promoting Liquid Demixing and Stress Granule Localization
- (2018) Leeanne McGurk et al. MOLECULAR CELL
- Systems-wide Analysis of Serine ADP-Ribosylation Reveals Widespread Occurrence and Site-Specific Overlap with Phosphorylation
- (2018) Sara C. Larsen et al. Cell Reports
- Nuclear poly(ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosis
- (2018) L. McGurk et al. Acta Neuropathologica Communications
- Poly(ADP-ribose) Engages the TDP-43 Nuclear-Localization Sequence to Regulate Granulo-Filamentous Aggregation
- (2018) Leeanne McGurk et al. BIOCHEMISTRY
- PARP1 Trapping by PARP Inhibitors Drives Cytotoxicity in Both Cancer Cells and Healthy Bone Marrow
- (2018) Todd A. Hopkins et al. MOLECULAR CANCER RESEARCH
- Poly(ADP-ribose) drives pathologic α-synuclein neurodegeneration in Parkinson’s disease
- (2018) Tae-In Kam et al. SCIENCE
- Synthesis and evaluation of an AZD2461 [18F]PET probe in non-human primates reveals the PARP-1 inhibitor to be non-blood-brain barrier penetrant
- (2018) Sean W. Reilly et al. BIOORGANIC CHEMISTRY
- PARP1 in Carcinomas and PARP1 Inhibitors as Antineoplastic Drugs
- (2017) Luyao Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Serine ADP-Ribosylation Depends on HPF1
- (2017) Juan José Bonfiglio et al. MOLECULAR CELL
- The multifaceted roles of PARP1 in DNA repair and chromatin remodelling
- (2017) Arnab Ray Chaudhuri et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Ferroptosis and cell death mechanisms in Parkinson's disease
- (2017) Stephanie J. Guiney et al. NEUROCHEMISTRY INTERNATIONAL
- PARP inhibitors: Synthetic lethality in the clinic
- (2017) Christopher J. Lord et al. SCIENCE
- Poly(ADP-ribose)polymerase-1 hyperactivation in neurodegenerative diseases: The death knell tolls for neurons
- (2017) Parimala Narne et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Pathology of Neurodegenerative Diseases
- (2017) Brittany N. Dugger et al. Cold Spring Harbor Perspectives in Biology
- Serine ADP-ribosylation reversal by the hydrolase ARH3
- (2017) Pietro Fontana et al. eLife
- Transcriptional Reprogramming and Resistance to Colonic Mucosal Injury in Poly(ADP-ribose) Polymerase 1 (PARP1)-deficient Mice
- (2016) Claire B. Larmonier et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- An Update on Poly(ADP-ribose)polymerase-1 (PARP-1) Inhibitors: Opportunities and Challenges in Cancer Therapy
- (2016) Ying-Qing Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Alpha-synuclein structure, functions, and interactions
- (2016) FatemehNouri Emamzadeh Journal of Research in Medical Sciences
- HPF1/C4orf27 Is a PARP-1-Interacting Protein that Regulates PARP-1 ADP-Ribosylation Activity
- (2016) Ian Gibbs-Seymour et al. MOLECULAR CELL
- Serine is a new target residue for endogenous ADP-ribosylation on histones
- (2016) Orsolya Leidecker et al. Nature Chemical Biology
- PARP-1 may be involved in angiogenesis in epithelial ovarian cancer
- (2016) Wei Wei et al. Oncology Letters
- FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of Chemotherapy
- (2015) G. Kim et al. CLINICAL CANCER RESEARCH
- The rise and fall of poly(ADP-ribose): An enzymatic perspective
- (2015) John M. Pascal et al. DNA REPAIR
- PARP-1 involvement in neurodegeneration: A focus on Alzheimer’s and Parkinson’s diseases
- (2015) Sara Martire et al. MECHANISMS OF AGEING AND DEVELOPMENT
- Mechanistic Dissection of PARP1 Trapping and the Impact on In Vivo Tolerability and Efficacy of PARP Inhibitors
- (2015) T. A. Hopkins et al. MOLECULAR CANCER RESEARCH
- PARP-1 Inhibition Is Neuroprotective in the R6/2 Mouse Model of Huntington’s Disease
- (2015) Antonella Cardinale et al. PLoS One
- Liquid demixing of intrinsically disordered proteins is seeded by poly(ADP-ribose)
- (2015) Matthias Altmeyer et al. Nature Communications
- Post-Translational Modifications of Histones That Influence Nucleosome Dynamics
- (2014) Gregory D. Bowman et al. CHEMICAL REVIEWS
- Poly(ADP-ribose): An organizer of cellular architecture
- (2014) Anthony K.L. Leung JOURNAL OF CELL BIOLOGY
- Automodification switches PARP-1 function from chromatin architectural protein to histone chaperone
- (2014) U. M. Muthurajan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Beyond DNA repair, the immunological role of PARP-1 and its siblings
- (2013) Maria Manuela Rosado et al. IMMUNOLOGY
- Effects of Poly (ADP-ribose) Polymerase Inhibitor 3-Aminobenzamide on Blood–Brain Barrier and Dopaminergic Neurons of Rats with Lipopolysaccharide-Induced Parkinson’s Disease
- (2013) Xiao-li Wu et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- PARP-1 and gene regulation: Progress and puzzles
- (2013) W. Lee Kraus et al. MOLECULAR ASPECTS OF MEDICINE
- ADP-ribosyl-acceptor hydrolase 3 regulates poly (ADP-ribose) degradation and cell death during oxidative stress
- (2013) M. Mashimo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- (ADP-ribose) polymerase 1 and AMP-activated protein kinase mediate progressive dopaminergic neuronal degeneration in a mouse model of Parkinson’s disease
- (2013) T W Kim et al. Cell Death & Disease
- A systematic analysis of the PARP protein family identifies new functions critical for cell physiology
- (2013) Sejal Vyas et al. Nature Communications
- Genetics of Parkinson's Disease
- (2013) C. Klein et al. Cold Spring Harbor Perspectives in Medicine
- Programmed Cell Death in Parkinson's Disease
- (2013) K. Venderova et al. Cold Spring Harbor Perspectives in Medicine
- Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
- (2012) J. Murai et al. CANCER RESEARCH
- Alpha-synuclein elicits glucose uptake and utilization in adipocytes through the Gab1/PI3K/Akt transduction pathway
- (2012) Gerardo Rodriguez-Araujo et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Histone ADP-Ribosylation Facilitates Gene Transcription by Directly Remodeling Nucleosomes
- (2012) R. Martinez-Zamudio et al. MOLECULAR AND CELLULAR BIOLOGY
- Poly(ADP-ribose) Polymerase-1 in Amyloid Beta Toxicity and Alzheimer's Disease
- (2012) Joanna B. Strosznajder et al. MOLECULAR NEUROBIOLOGY
- Structural Basis for DNA Damage-Dependent Poly(ADP-ribosyl)ation by Human PARP-1
- (2012) M.-F. Langelier et al. SCIENCE
- Signaling Mechanism of Poly(ADP-Ribose) Polymerase-1 (PARP-1) in Inflammatory Diseases
- (2011) Xueqing Ba et al. AMERICAN JOURNAL OF PATHOLOGY
- β-amyloid activates PARP causing astrocytic metabolic failure and neuronal death
- (2011) Rosella Abeti et al. BRAIN
- The role of PARP in DNA repair and its therapeutic exploitation
- (2011) M Javle et al. BRITISH JOURNAL OF CANCER
- Poly(ADP-ribose)polymerase-1 modulates microglial responses to amyloid β
- (2011) Tiina M Kauppinen et al. Journal of Neuroinflammation
- -Synuclein Negatively Regulates Protein Kinase C Expression to Suppress Apoptosis in Dopaminergic Neurons by Reducing p300 Histone Acetyltransferase Activity
- (2011) H. Jin et al. JOURNAL OF NEUROSCIENCE
- Association analysis of PARP1 polymorphisms with Parkinson’s disease
- (2011) Laura Brighina et al. PARKINSONISM & RELATED DISORDERS
- Dissociation of Progressive Dopaminergic Neuronal Death and Behavioral Impairments by Bax Deletion in a Mouse Model of Parkinson's Diseases
- (2011) Tae Woo Kim et al. PLoS One
- Apoptosis-inducing factor mediates dopaminergic cell death in response to LPS-induced inflammatory stimulusEvidence in Parkinson's disease patients
- (2010) M.A. Burguillos et al. NEUROBIOLOGY OF DISEASE
- PARP1 ADP-ribosylates lysine residues of the core histone tails
- (2010) Simon Messner et al. NUCLEIC ACIDS RESEARCH
- -Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro
- (2010) J. Burre et al. SCIENCE
- Cell death pathways in Parkinson’s disease: proximal triggers, distal effectors, and final steps
- (2009) Oren A. Levy et al. APOPTOSIS
- Honokiol protects rats against eccentric exercise-induced skeletal muscle damage by inhibiting NF-κB induced oxidative stress and inflammation
- (2009) Jasson Chiang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- PARP inhibitors: New partners in the therapy of cancer and inflammatory diseases
- (2009) Andreína Peralta-Leal et al. FREE RADICAL BIOLOGY AND MEDICINE
- Parthanatos, a messenger of death
- (2009) Karen Kate David Frontiers in Bioscience-Landmark
- Molecular mechanism of poly(ADP-ribosyl)ation by PARP1 and identification of lysine residues as ADP-ribose acceptor sites
- (2009) Matthias Altmeyer et al. NUCLEIC ACIDS RESEARCH
- Activation of the abundant nuclear factor poly(ADP-ribose) polymerase-1 by Helicobacter pylori
- (2009) C. W. Nossa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mitochondria, oxidative stress and PARP-1 network: a new target for neuroprotective effects of tetracyclines?
- (2008) Daniele Orsucci et al. JOURNAL OF PHYSIOLOGY-LONDON
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now